FinanceCity
HealthcareNSE · BSE

Alkem Laboratories Limited

ALKEM · ISIN INE540L01014

Share price

₹5,343 +0.16%

Market capitalisation

₹63878 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹63878 Cr

Current price

₹5,343

+0.16% today

52W high

₹5,934

52W low

₹4,716

Stock P/E

27.74

P/B ratio

4.62

02 · Per share & returns

EPS (TTM)

₹193

Book value

₹1,155

ROE

17.56%

ROA

8.50%

Dividend yield

0.99%

Beta

0.27

03 · Financials (TTM)

By the numbers

Revenue

₹14712 Cr

+14.60% YoY

EBITDA

₹3005 Cr

Net profit

₹2302 Cr

-22.70% YoY

Profit margin

15.64%

Operating margin

11.42%

Total debt

₹2047 Cr

Total cash

₹4993 Cr

Debt / equity

0.14x

Current ratio

2.55x

Payout ratio

26.49%

04 · Analyst view

Target price

₹5,956

Upside

+11.49%

Consensus

BUY

Analysts

20

05 · Shareholding pattern

Who owns ALKEM?

  • Promoters

    51.20%

    Founders & promoter group

  • Institutions

    25.40%

    FII + DII

  • Public

    23.40%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
ALKEM
Exchange
NSE · BSE
CIN
ISIN
INE540L01014
BSE code
539523
Sector
Healthcare
Industry
Healthcare
Face value
₹2
Listing date
22 Dec 2015
Employees
Headquarters
Mumbai, India

07 · About

What is Alkem Laboratories Limited?

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of Alkem Laboratories Limited?+

The Corporate Identity Number for Alkem Laboratories Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Alkem Laboratories Limited?+

Promoter holding in ALKEM is approximately 51.20%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Alkem Laboratories Limited?+

Alkem Laboratories Limited (ALKEM) has a market capitalisation of approximately ₹63878 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →